Drug class

Anticonvulsant - Triazole Derivatives

Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide. Read more about Anticonvulsant - Triazole Derivatives

13 drugs in this class 12 manufacturers

Advertisement

Drugs in Anticonvulsant - Triazole Derivatives

Showing 1–9 of 13 drugs

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
Mylan Pharmaceuticals

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
NORTHSTAR RX LL

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
CAMBER PHARMACE

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
MICRO LABS USA,

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
AUROBINDO PHARM

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
ASCEND LABORATO

RUFINAMIDE

ANTICONVULSANTS · LENNOX-GASTAUT EPILEPSY
LUPIN PHARMACEU
Filter & compare in the drug finder → Opens the drug finder with Anticonvulsant - Triazole Derivatives preselected. Add indication or manufacturer filters there.

About Anticonvulsant - Triazole Derivatives.

Anticonvulsant triazole derivatives are a chemically distinct class of antiepileptic agents defined by a five-membered heterocyclic triazole ring, represented clinically by rufinamide.

These agents primarily exert their anticonvulsant effects by modulating voltage-gated sodium channels, specifically prolonging their inactivated state to suppress high-frequency, repetitive neuronal firing without significantly altering normal baseline transmission.

Within clinical neurology, this class is primarily utilized as adjunctive pharmacotherapy in the management of severe, drug-resistant seizure disorders, most notably Lennox-Gastaut syndrome, as well as refractory focal-onset seizures.